DekaBank Deutsche Girozentrale Acquires 414 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

DekaBank Deutsche Girozentrale boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 1.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,475 shares of the company’s stock after acquiring an additional 414 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Bath & Body Works were worth $1,349,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. grew its position in Bath & Body Works by 12.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 19,672 shares of the company’s stock valued at $940,000 after acquiring an additional 2,228 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of Bath & Body Works by 3.9% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 34,484 shares of the company’s stock worth $1,648,000 after purchasing an additional 1,301 shares during the last quarter. Vontobel Holding Ltd. increased its position in shares of Bath & Body Works by 253.4% during the 1st quarter. Vontobel Holding Ltd. now owns 44,967 shares of the company’s stock worth $2,244,000 after purchasing an additional 32,242 shares in the last quarter. Candriam Luxembourg S.C.A. lifted its holdings in Bath & Body Works by 127.4% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 27,922 shares of the company’s stock valued at $1,335,000 after purchasing an additional 15,642 shares during the last quarter. Finally, Baird Financial Group Inc. boosted its position in Bath & Body Works by 54.3% in the first quarter. Baird Financial Group Inc. now owns 113,805 shares of the company’s stock valued at $5,440,000 after buying an additional 40,046 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Insiders Place Their Bets

In other news, insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares of the company’s stock, valued at approximately $2,248,548.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.19% of the company’s stock.

Bath & Body Works Stock Down 2.2 %

BBWI stock opened at $45.22 on Monday. Bath & Body Works, Inc. has a twelve month low of $27.30 and a twelve month high of $50.34. The business’s fifty day moving average is $46.15 and its 200-day moving average is $39.81. The company has a market cap of $10.17 billion, a P/E ratio of 11.75, a price-to-earnings-growth ratio of 1.47 and a beta of 1.86.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.21. The firm had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The company’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.86 earnings per share. Research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.77%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works’s payout ratio is presently 20.78%.

Analysts Set New Price Targets

Several research firms have recently weighed in on BBWI. Barclays lowered shares of Bath & Body Works from an “overweight” rating to an “equal weight” rating and raised their price objective for the stock from $37.00 to $45.00 in a report on Thursday, January 4th. Piper Sandler raised their target price on Bath & Body Works from $44.00 to $45.00 and gave the company a “neutral” rating in a research note on Tuesday, April 9th. The Goldman Sachs Group lifted their price target on Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a report on Monday, March 4th. Telsey Advisory Group reissued an “outperform” rating and set a $53.00 price objective on shares of Bath & Body Works in a report on Friday, April 5th. Finally, UBS Group upped their target price on shares of Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a research report on Monday, March 4th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $46.33.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.